Deutsche Tageszeitung - Bollywood actor Tiger Shroff shot at in Mumbai, three suspects held: police

Weather - Berlin 11°C

Bollywood actor Tiger Shroff shot at in Mumbai, three suspects held: police

BOULEVARD 19.10.2026

Bollywood actor Tiger Shroff shot at in Mumbai, three suspects held: police / Photo: © AFP/File

Indian actor Tiger Shroff was shot at in Mumbai on Sunday, police said, adding that three suspects have been detained.

Change text size:

Shooters opened fire at the 36-year-old actor as he was leaving a private event in the city's upscale Juhu area on Sunday evening, according to Police official Mohit Garg.

Aside from being India's financial capital, Mumbai is also the heart of Bollywood, the country's Hindi-language film industry.

"Tiger Shroff is safe and Mumbai police has deployed different teams to investigate further," Garg told reporters.

Two people were injured in the incident, including the actor's driver, though Shroff did not sustain gunshot wounds, police said.

Three suspects have been rounded up in Rajasthan, another Indian state.

"Preliminary questioning revealed that two of them have one case each against them, one related to theft and the other under the Arms Act," police official Tejaswani Gautam told reporters.

Police have yet to establish a motive for the shooting.

Shroff is known for action films including the "Baaghi" franchise and "War".

(V.Sørensen--DTZ)

Featured

Indonesia fires burned over 1.9 mn hectares through September: monitor

Fires in Indonesia burned through over 1.9 million hectares between January and the end of September this year, a monitor analysing satellite imagery said on Monday.

One year after Louvre heist, where are the missing jewels?

One year after a stunning break-in at the Louvre Museum, the four main suspects are in jail awaiting trial, but police appear to have run out of leads to locate the stolen crown jewels.

BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate

VANCOUVER, BC / ACCESS Newswire / October 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce two major development milestones for BNT23001, its proprietary sublingual Cladribine oral dissolvable film ("ODF") drug candidate for the treatment of relapsing forms of multiple sclerosis ("MS"). The Company has completed Good Manufacturing Practice ("GMP") manufacturing of approximately 1,500 investigational Cladribine films and submitted its Clinical Trial Application ("CTA") through the European Union's Clinical Trials Information System ("CTIS") on October 16, 2026.

Venezuela opposition alliance reaffirms Nobel laureate Machado as leader

An alliance of Venezuelan opposition parties on Sunday reaffirmed exiled Nobel Peace Prize laureate Maria Corina Machado as its leader, increasing pressure on interim authorities to allow her return.

Change text size: